These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9849692

  • 1. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
    Abonour R, Scott KM, Kunkel LA, Robertson MJ, Hromas R, Graves V, Lazaridis EN, Cripe L, Gharpure V, Traycoff CM, Mills B, Srour EF, Cornetta K.
    Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
    [Abstract] [Full Text] [Related]

  • 2. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
    Alegre A, Tomás JF, Martínez-Chamorro C, Gil-Fernández JJ, Fernández-Villalta MJ, Arranz R, Díaz MA, Granda A, Bernardo MR, Escudero A, López-Lorenzo JL, Fernández-Rañada JM.
    Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
    [Abstract] [Full Text] [Related]

  • 3. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
    Dyson PG, Horvath N, Joshua D, Barrow L, Van Holst NG, Brown R, Gibson J, To LB.
    Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I, Bredeson C, Atkins H, McDiarmid S, Hamelin L, Hopkins H, Perry G, Genest P, Huebsch L.
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [Abstract] [Full Text] [Related]

  • 5. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 6. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J, Bladé J, Lahuerta JJ, Ribera JM, Martínez R, Alegre A, García-Laraña J, Fernández P, Sureda A, de Arriba F, Carrera D, Besalduch J, García Boyero R, Palomera Bernal L, Hernández MT, García PR, Pérez-Calvo J, Alcalá A, Casado LF, San Miguel J.
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.
    Lazarus HM, Pecora AL, Shea TC, Koç ON, White JM, Gabriel DA, Cooper BW, Gerson SL, Krieger M, Sing AP.
    Bone Marrow Transplant; 2000 Mar; 25(5):559-66. PubMed ID: 10713636
    [Abstract] [Full Text] [Related]

  • 9. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 10. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
    Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T, Holmberg L, McSweeney P, Beach K, MacLeod B, Appelbaum F, Bensinger WI.
    Bone Marrow Transplant; 1998 Jun 15; 21(12):1253-62. PubMed ID: 9674860
    [Abstract] [Full Text] [Related]

  • 11. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.
    Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ.
    Bone Marrow Transplant; 1996 May 15; 17(5):723-7. PubMed ID: 8733688
    [Abstract] [Full Text] [Related]

  • 12. High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
    Patriarca F, Damiani D, Fanin R, Grimaz S, Geromin A, Cerno M, Sperotto A, Silvestri F, Zaja F, Baccarani M.
    Haematologica; 2000 Mar 15; 85(3):269-74. PubMed ID: 10702815
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M, Hilgenfeld E, Fietz T, Hoppe B, Koenigsmann M, Hoffmann M, Knauf WU, Cassens U, Sibrowski W, Kienast J, Thiel E, Berdel WE.
    Clin Cancer Res; 1999 May 15; 5(5):1035-40. PubMed ID: 10353736
    [Abstract] [Full Text] [Related]

  • 14. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May 15; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 15. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells.
    Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballester O, Tarantolo S, Stiff P, Kuhn D, Scherzo E, Sing A, Jacobs C, White JM, DiPersio J.
    Bone Marrow Transplant; 1999 Jul 15; 24(1):25-8. PubMed ID: 10435730
    [Abstract] [Full Text] [Related]

  • 16. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study.
    Imai Y, Chou T, Tobinai K, Tanosaki R, Morishima Y, Ogura M, Shimazaki C, Taniwaki M, Hiraoka A, Tanimoto M, Koike T, Kogawa K, Hirai H, Yoshida T, Tamura K, Kishi K, Hotta T, CliniMACS Study Group.
    Bone Marrow Transplant; 2005 Mar 15; 35(5):479-87. PubMed ID: 15654349
    [Abstract] [Full Text] [Related]

  • 17. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May 15; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

  • 18. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM, Cavo M, Fortuna A.
    J Hematother; 1996 Aug 15; 5(4):339-49. PubMed ID: 8877709
    [Abstract] [Full Text] [Related]

  • 19. Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma.
    Webb IJ, Scholssman RL, Jiroutek M, Doss D, Cohen CA, Freeman A, Schott DM, Anderson KC.
    Cytotherapy; 1999 Aug 15; 1(3):175-82. PubMed ID: 12881173
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD.
    Stem Cells; 2007 Jan 15; 25(1):228-35. PubMed ID: 17204607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.